Some novel bioactivities of Virgibacillus halodenitrificans carotenoids, isolated from Wadi El-Natrun lakes
- PMID: 37869364
- PMCID: PMC10587757
- DOI: 10.1016/j.sjbs.2023.103825
Some novel bioactivities of Virgibacillus halodenitrificans carotenoids, isolated from Wadi El-Natrun lakes
Abstract
Carotenoids come in second among the most frequent natural pigments and are utilized in medications, nutraceuticals, cosmetics, food pigments, and feed supplements. Based on recent complementary work, Virgibacillus was announced for the first time as a member of Wadi El-Natrun salt and soda lakes microbiota, identified as Virgibacillus halodenitrificans, and named V. halodenitrificans DASH; hence, this work aimed to investigate several in vitro medicinal bioactivities of V. halodenitrificans DASH carotenoids. The carotenoid methanolic extract showed antioxidant activity based on diphenylpicrylhydrazyl (DPPH) scavenging capacity with a half-maximal concentration (IC50) of 1.6 mg/mL as well as nitric oxide (NO) scavenging action expressed by an IC50 of 46.4 µg/mL. The extract showed considerable inhibitory activity for alpha-amylase (α-amylase) and alpha-glucosidase (α-glucosidase) enzymes (IC50 of 100 and 173.4 μg/mL, respectively). Moreover, the extract displayed selective anticancer activity against Caco-2 (IC50 = 138.96 µg/mL) and HepG-2 cell lines (IC50 = 31.25 µg/mL), representing colorectal adenocarcinoma and hepatoblastoma. Likewise, the extract showed 98.9 % clearance for human hepatitis C virus (HCV) using reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR), HCV-NS5B polymerase activity inhibition (IC50 = 27.4 µg/mL), and selective inhibitory activity against human coronavirus (HCoV 229E) using the plaque reduction assay (IC50 = 53.5 µg/mL). As far as we can tell, the anticancer, antiviral, and antidiabetic attributes of Virgibacillus carotenoids are, de novo, reported in this work which accordingly invokes further exploration of the other medicinal, biotechnological, and industrial applications of Virgibacillus and haloalkaliphilic bacteria carotenoids.
Keywords: Anticancer; Antidiabetes; Antioxidant; Antiviral; Carotenoids; Halophilic.
© 2023 Published by Elsevier B.V. on behalf of King Saud University.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





References
-
- Ajila C., Brar S. In: Nutrition, Diet, and Cancer. Shankar S., Srivastava R.K., editors. Springer; USA: 2012. Role of dietary antioxidants in cancer; pp. 377–412.
-
- Antwi S.O., Steck S.E., Su L.J., Hebert J.R., Zhang H., Craft N.E., Fontham E.T.H., Smith G.J., Bensen J.T., Mohler J.L., Arab L. Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP) Prostate. 2016;76(12):1053–1066. doi: 10.1002/pros.23189. - DOI - PMC - PubMed
-
- Arunachalam K., Appadorai R.A.J. Antioxidant potential and biochemical evaluation of metabolites from the marine bacteria Virgibacillus sp. associated with the sponge Callyspongia diffusa. Free. Radical. Antioxid. 2013;3(1):47–51. doi: 10.1016/j.fra.2013.04.004. - DOI
-
- Atalay P.B., Kuku G., Tuna B.G. Effects of carbendazim and astaxanthin co-treatment on the proliferation of MCF-7 breast cancer cells. Vitr. Cell. Dev. Biol. Anim. 2018;55:113–119. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials